| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/10/1998 | US5717092 Compounds with improved multi-drug resistance activity |
| 02/10/1998 | US5716994 Plant extracts |
| 02/10/1998 | US5716988 Ready-to-use; parenteral administering |
| 02/10/1998 | US5716982 Retinoids and methods of use of same |
| 02/10/1998 | US5716979 Tachykinin antagonists |
| 02/10/1998 | US5716963 Diazaquinomycin derivative |
| 02/10/1998 | US5716959 Administering substituted piperazines having hydroxy- or amino-alkyl groups on one nitrogen and carboxylic, phosphoric or sulfonic alkyl groups on the other nitrogen, for treatment of cancer and autoimmune diseases |
| 02/10/1998 | US5716953 Modifiers of gastrin and cholecystokinins |
| 02/10/1998 | US5716945 Antiinflammatory agents; immunostimulation; cell differentiation; antigrowth agents |
| 02/10/1998 | US5716936 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 02/10/1998 | US5716934 Eck receptor ligands |
| 02/10/1998 | US5716930 Polypeptide from genetically engineered cells |
| 02/10/1998 | US5716624 Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 02/10/1998 | US5716620 Vaccines, diagnostic immunoassay |
| 02/10/1998 | US5716612 Desensitizing the cancer cell drug resistance |
| 02/10/1998 | US5716595 Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments |
| 02/10/1998 | US5715835 Methods for treating and reducing the potential for cardiovascular disease using methioninase compositions |
| 02/10/1998 | CA2112351C Method of making camptothecin and camptothecin analogs |
| 02/10/1998 | CA2094914C Anthracycline analogues bearing latent alkylating substituents |
| 02/06/1998 | CA2212204A1 8-substituted b-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators |
| 02/05/1998 | WO1998004917A1 Boron neutron capture therapy using pre-targeting methods |
| 02/05/1998 | WO1998004728A1 Recombinant pox virus for immunization against tumor-associated antigens |
| 02/05/1998 | WO1998004727A1 Recombinant pox virus for immunization against tumor-associated antigens |
| 02/05/1998 | WO1998004726A1 Hsv strain lacking functional icp27 and icp34.5 genes |
| 02/05/1998 | WO1998004720A1 Method and reagents for genetic immunization |
| 02/05/1998 | WO1998004712A2 Substrate trapping protein tyrosine phosphatases |
| 02/05/1998 | WO1998004705A1 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 02/05/1998 | WO1998004702A2 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
| 02/05/1998 | WO1998004694A2 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1998004693A2 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1998004583A1 Conformationally constrained backbone cyclized somatostatin analogs |
| 02/05/1998 | WO1998004582A1 Isolated peptides derived from mage-2 |
| 02/05/1998 | WO1998004581A1 Dolastatin pentapeptide derivatives and their use as antitumor agents |
| 02/05/1998 | WO1998004576A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/05/1998 | WO1998004553A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 02/05/1998 | WO1998004552A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 02/05/1998 | WO1998004551A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 02/05/1998 | WO1998004545A1 Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase |
| 02/05/1998 | WO1998004527A1 Pyranoindole and carbazole inhibitors of cox-2 |
| 02/05/1998 | WO1998004524A1 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 02/05/1998 | WO1998004291A1 2-methoxyestradiol-induced apoptosis in cancer cells |
| 02/05/1998 | WO1998004290A2 Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders |
| 02/05/1998 | WO1998004284A1 Novel genes of kaposi's sarcoma associated herpesvirus |
| 02/05/1998 | WO1998004282A1 Cancer immunotherapy using autologous tumor cells combined with allogeneic cytokine-secreting cells |
| 02/05/1998 | WO1998004278A2 Tetrapeptide derivatives of dolastatin as antitumor agents |
| 02/05/1998 | WO1998004277A1 Peptidyl prodrugs and methods of making and using the same |
| 02/05/1998 | WO1998004257A1 Phosphatase inhibitors and methods of use thereof |
| 02/05/1998 | WO1998004255A1 Amino acid composition and use thereof in treating tumor growth and metastasis |
| 02/05/1998 | WO1998004251A1 Use of amines to produce drugs for preventing tumour cell proliferation |
| 02/05/1998 | WO1998004242A2 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
| 02/05/1998 | WO1997048368A3 Naphthyridines which affect il-4 and g-csf |
| 02/05/1998 | WO1997047744A3 T-cell selective interleukin-4 agonists |
| 02/05/1998 | WO1997040069A3 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1997038084A3 Polynucleotides derived from a pbmc cdna library encoding secreted proteins |
| 02/05/1998 | WO1997032991A3 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
| 02/05/1998 | DE4447715C2 Oestrogen compsn contg. 3-sulphamoyl:oxy-oestratriene cpd. |
| 02/05/1998 | DE4447714C2 Oestrogen compsn contg. 3-sulphamoyl:oxy-oestratriene cpd. |
| 02/05/1998 | CA2289699A1 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | CA2262533A1 2-methoxyestradiol and p53-induced apoptosis in cancer cells |
| 02/05/1998 | CA2262440A1 Substrate trapping protein tyrosine phosphatases |
| 02/05/1998 | CA2262092A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 02/05/1998 | CA2262089A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 02/05/1998 | CA2262088A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 02/05/1998 | CA2262006A1 Method and reagents for genetic immunization |
| 02/05/1998 | CA2261990A1 Recombinant pox virus for immunization against tumor-associated antigens |
| 02/05/1998 | CA2261886A1 Peptidyl prodrugs and methods of making and using the same |
| 02/05/1998 | CA2261837A1 Cancer immunotherapy using autologous tumor cells combined with allogeneic cytokine-secreting cells |
| 02/05/1998 | CA2261793A1 Phosphatase inhibitors and methods of use thereof |
| 02/05/1998 | CA2261791A1 Boron neutron capture therapy using pre-targeting methods |
| 02/05/1998 | CA2261718A1 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
| 02/05/1998 | CA2261588A1 Pyranoindole and carbazole inhibitors of cox-2 |
| 02/05/1998 | CA2261581A1 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | CA2261164A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/05/1998 | CA2260886A1 Amino acid composition and use thereof in treating tumor growth and metastasis |
| 02/05/1998 | CA2259924A1 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
| 02/04/1998 | EP0822255A2 CHO (Chinese Hamster Ovary) glycosylated antibodies and their use in therapy |
| 02/04/1998 | EP0822199A2 N-terminally monopegylated polypeptides and process for their preparation. |
| 02/04/1998 | EP0822192A2 Inhibitors of beta-glucuronidase |
| 02/04/1998 | EP0822190A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/04/1998 | EP0822186A2 L-tert-leucine-2-pyridylamide |
| 02/04/1998 | EP0821960A1 Use of xanthine derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821739A1 An adenovirus helper-virus system |
| 02/04/1998 | EP0821728A1 Tie-2 ligands, methods of making and uses thereof |
| 02/04/1998 | EP0821696A1 Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
| 02/04/1998 | EP0821692A1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 02/04/1998 | EP0821691A1 Methods of synthesizing gm2 |
| 02/04/1998 | EP0821689A1 Tumor protease activated prodrugs of phosphoramide mustard analogs |
| 02/04/1998 | EP0821680A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 02/04/1998 | EP0821675A1 Novel hydroxamic acid and amino-carboxylate compounds as metalloprotease and tnf inhibitors |
| 02/04/1998 | EP0821671A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors |
| 02/04/1998 | EP0821669A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors |
| 02/04/1998 | EP0821668A1 Derivatives of succinamide and their use as metalloproteinase inhibitor |
| 02/04/1998 | EP0821666A1 Derivatives of succinamide and their use as metalloproteinase inhibitors |
| 02/04/1998 | EP0821665A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase |
| 02/04/1998 | EP0821594A1 Compounds for cancer imaging and therapy |
| 02/04/1998 | EP0821586A1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
| 02/04/1998 | EP0671933B1 Novel uses of il-10 |
| 02/04/1998 | EP0651800B1 Basophil granule proteins |
| 02/04/1998 | EP0460072B1 Human elastase inhibitor |
| 02/04/1998 | CN1172485A Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |